Chemical Compound

TENOFOVIR ALAFENAMIDE

CAS Registry Number 379270-37-8

Back to search Request a Quote

Primary Record

TENOFOVIR ALAFENAMIDE

In stock: 8,794 g
Purity: 98.1 %
CAS: 379270-37-8

Compound Identifiers & Properties

CAS: 379270-37-8
PubChem CID: 9574768
SMILES: C[C@H](CN1C=NC2=C(N=CN=C21)N)OC[P@@](=O)(N[C@@H](C)C(=O)OC(C)C)OC3=CC=CC=C3
Canonical SMILES: CC(C)OC(=O)[C@H](C)N[P@](=O)(CO[C@H](C)Cn1cnc2c(N)ncnc21)Oc1ccccc1

Names & Synonyms

TENOFOVIR ALAFENAMIDE
GS-7340
379270-37-8
Vemlidy
TFV Alafenamide
tenofovir alagenamide
Tenofovir alafenamida
UNII-EL9943AG5J
RefChem:56250
EL9943AG5J
GS 7340
MFCD23843796
Tenofovir Alafenamide [USAN]
UNII-J4414G3BUK
C21H29N6O5P
CHEBI:90926
Tenofovir Alafenamide fumarate
DTXSID50958941
GS7340
J4414G3BUK
orb1305529
SCHEMBL3107149
Tenofovir Alafenamide [USAN:INN]
CHEMBL2107825
GS-7340 Tenofovir alafenamide
SCHEMBL29351625
GTPL14054
KS-00000PWZ
EX-A610
GS-7340; Tenofovir alafenamide
GS-734003
LDEKQSIMHVQZJK-CAQYMETFSA-N
Tenofovir alafenamide (free base)
AIDS046774
BDBM689130
DTXCID401386833
GLXC-07489
Tenofovir alafenamide (USAN/INN)
TENOFOVIR ALAFENAMIDE [MI]
US12049474, Compound TAF
TENOFOVIR ALAFENAMIDE [INN]
Tenofovir Alafenamide (GS-7340)
4863AB
EBC-27200
AKOS016009341
TENOFOVIR ALAFENAMIDE [WHO-DD]
ZINC100055899
ACN-037529
CCG-269506
CID9574768
CS-3366
DB09299
FT76562
GS-7339
NCGC00390564-03
NCGC00390564-04
AC-29893
AJ-67913
AS-55942
BC600709
GS-7340?
HY-15232
SC-20288
SY115605
B8021
NS00073274
S7856
Tenofovir Alafenamide (Prodrug of tenofovir)
(S)-Isopropyl 2-(((S)-((((R)-1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)(phenoxy)phosphoryl)amino)propanoate
D10428
383365-04-6
EN300-7398411
A856132
propan-2-yl (2S)-2-[[[(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethyl-phenoxyphosphoryl]amino]propanoate
Q22075912
L-Alanine, N-((S)-(((1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy)methyl)phenoxyphosphinyl)-, 1-methylethyl ester
TAF
TENOFOVIR ALAFENAMIDE(Discontinued,See C4X-179757)
B0084-463638
isopropyl ((S)-((((R)-1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)(phenoxy)phosphoryl)-L-alaninate
propan-2-yl (2S)-2-{[(S)-({[(2R)-1-(6-amino-9H-purin-9-yl)propan-2-yl]oxy}methyl)(phenoxy)phosphoryl]amino}propanoate
Sp-Tenofovir-phosphonamidate, phenyl, L-alanine isopropyl ester
isopropyl (2S)-2-[[[(1R)-2-(6-aminopurin-9-yl)-1-methyl-ethoxy]methyl-phenoxy-phosphoryl]amino]propanoate
propan-2-yl N-[(S)-({[(2R)-1-(6-amino-9H-purin-9-yl)propan-2-yl]oxy}methyl)(phenoxy)phosphoryl]-L-alaninate
(S)-Isopropyl 2-((S)-(((R)-1-(6-amino-9H-purin-9-yl)propan-2-yloxy)methyl)(phenoxy)phosphorylamino)propanoate
1-METHYLETHYL N-((S)-(((1R)-2-(6-AMINO-9H-PURIN-9-YL)-1-METHYLETHOXY)METHYL)PHENOXYPHOSPHINYL)-L-ALANINATE
9-[(r)-2-[[(s)-[[(s)-1-(isopropoxycarbonyl)ethyl]amino]phenoxyphosphinyl]methoxy]propyl]adenine
Isopropyl (S)-2-[[(S)-[[[(R)-1-(6-Amino-9-purinyl)-2-propyl]oxy]methyl](phenoxy)phosphoryl]amino]propanoate
L-Alanine, N-((R)-(((1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy)methyl)phenoxyphosphinyl)-, 1-methylethyl ester
L-Alanine, N-[(S)-[[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]phenoxyphosphinyl]-, 1-methylethyl ester
L-Alanine, Sp-N-[[[[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethyl]oxy]methyl]phenoxyphosphinyl]-, isopropyl ester
N-((R)-(((1R)-2-(6-Amino-9H-purin-9-yl)-1-methylethoxy)methyl)phenoxyphosphinyl)-L-alanine 1-methylethyl ester
N-[(R)-[[(1R)-2-(6-Amino-9H-purin-9-yl)-1-methylethoxy]methyl]phenoxyphosphinyl]-L-alanine 1-Methylethyl Ester
N-[(R)-[[(1R)-2-(6-Amino-9H-purin-9-yl)-1-methylethoxy]methyl]phenoxyphosphinyl]-L-alanine 1-Methylethyl Ester; L-Alanine, N-[(R)-[[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]phenoxyphosphinyl]-, 1-methylethyl ester (9CI, ACI); N-[(R)-[[(1R)-2-(6-Amino-9H-purin-9-yl)-1-methylethoxy]methyl]phenoxyphosphinyl]-L-alanine 1-methylethyl ester (ACI); GS 7339
propan-2-yl (2S)-2-(((S)-((((2R)-1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)(phenoxy)phosphoryl)amino)propanoate
Propan-2-yl N-[(S)-({[(2R)-1-(6-Amino-9H-purin-9-yl)propan-2-yl]-oxy}methyl)(phenoxy)phosphoryl]-l-alaninate, (2E)-But-2-enedioate (2:1)